Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
2018 · Nature Medicine · 284 citations
https://doi.org/10.1038/nm.4484
T
Tony Andreas Müller
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
501
Citations
10
h-index
12
i10-index
Tony Andreas Müller is an academic researcher from University of Cologne. The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Phagocytosis and Immune Regulation & Ubiquitin and proteasome pathways. The author has an h-index of 10, co-authored 38 publications.
ORCID: 0000-0002-4139-2392Papers by this author
worksDepletion of STAT5 blocks TEL–SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in mice
2014 · Blood Cancer Journal · 17 citations
https://doi.org/10.1038/bcj.2014.53
Efficacy of JAK1/2 inhibition in murine myeloproliferative neoplasms is not mediated by targeting oncogenic signaling
2025 · Nature Communications · 4 citations
https://doi.org/10.1038/s41467-025-60019-6
Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignancies
2025 · Signal Transduction and Targeted Therapy · 0 citations
https://doi.org/10.1038/s41392-025-02491-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat